Mostrando 3 resultados de: 3
Filtros aplicados
Publisher
F1000Research(1)
International Journal of Molecular Sciences(1)
Journal of Diabetes Research(1)
Origen
scopus(3)
Non-HDL cholesterol is better than ldl-c at pbkp_redicting atherosclerotic cardiovascular disease risk factors clustering, even in subjects with near-to-normal triglycerides: A report from a venezuelan population
ArticleAbstract: Background: Non-high density lipoprotein cholesterol (non-HDL-c) has emerged as an important tool inPalabras claves:ASCVD, cholesterol, Coronary artery disease, LDL-c, Non-HDL-c, risk factorAutores:de Bravo M.C., D’Addosio R., Graterol M., Graterol R., Hoedebecke K., Lameda V., Martínez M.S., Olivar L.C., Ortega A., Ramírez P., Rastogi S., Rojas E.R., Rojas M., Rojas-Quintero J., Salazar-Vílchez J., Torres W., Valmore Bermúdez, Wilches S.Fuentes:scopusRole of endocrine-disrupting chemicals in the pathogenesis of non-alcoholic fatty liver disease: A comprehensive review
ReviewAbstract: Non-alcoholic fatty liver disease (NAFLD) is considered the most common liver disorder, affecting arPalabras claves:Endocrine-disrupting chemicals, Environmental pollutants, Exposure, Liver disorder, Non-alcoholic fatty liver diseaseAutores:Cano G., Cano R.A., Dávila L.C.A., Diaz M.P., Gomez Y., González M.C., Manzano A., Ortega A., Parra H., Pérez J.L., Rojas-Quintero J., Valero-Cedeño N.J., Valmore Bermúdez, Veliz T.Fuentes:scopusSGLT2i and GLP-1RA in Cardiometabolic and Renal Diseases: From Glycemic Control to Adipose Tissue Inflammation and Senescence
ReviewAbstract: Background. Over the last few years, the use of sodium-glucose cotransporter 2 inhibitors (SGLT2i) aPalabras claves:Autores:D’marco L., Morillo V., Nava M., Ortega A., Parra H., Rojas-Quintero J., Suarez M.K., Teruel J.L., Valmore Bermúdez, Villasmil N.Fuentes:scopus